Covered recipient · General Payments record
JORGE VALENZUELA OLIVER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,115.59
- Reported across 166 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $604.07 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $134.94 | 1 |
| Lilly USA, LLC | $107.65 | 5 |
| GlaxoSmithKline, LLC. | $71.12 | 4 |
| DEXCOM, INC. | $60.38 | 3 |
| Astellas Pharma US Inc | $52.68 | 2 |
| Amgen Inc. | $36.69 | 2 |
| Novo Nordisk AS | $36.28 | 2 |
| ABBVIE INC. | $28.77 | 1 |
| Acerta Pharma LLC | $24.20 | 1 |
| OptiNose US, Inc. | $19.92 | 1 |
| Merck Sharp & Dohme Corporation | $15.73 | 1 |
| SHIELD THERAPEUTICS INC | $15.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.77 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106266504 | CMS |
| Amgen Inc. | $14.91 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111730987 | CMS |
| Amgen Inc. | $21.78 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117404503 | CMS |
| Astellas Pharma US Inc | $24.86 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139313726 | CMS |
| Astellas Pharma US Inc | $27.82 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139435374 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.20 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104726599 | CMS |
| Dexcom, Inc. | $17.27 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153310829 | CMS |
| Dexcom, Inc. | $19.73 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153310831 | CMS |
| Dexcom, Inc. | $23.38 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153310833 | CMS |
| GlaxoSmithKline, LLC. | $19.66 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116548397 | CMS |
| GlaxoSmithKline, LLC. | $21.45 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116662705 | CMS |
| GlaxoSmithKline, LLC. | $15.30 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116158166 | CMS |
| GlaxoSmithKline, LLC. | $14.71 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116627674 | CMS |
| Lilly USA, LLC | $13.37 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135096764 | CMS |
| Lilly USA, LLC | $25.46 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135081638 | CMS |
| Lilly USA, LLC | $16.24 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135099524 | CMS |
| Lilly USA, LLC | $25.74 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135096766 | CMS |
| Lilly USA, LLC | $26.84 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135073735 | CMS |
| Medtronic, Inc. | $134.94 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119463985 | CMS |
| Merck Sharp & Dohme LLC | $15.73 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141737403 | CMS |
| Novo Nordisk Inc | $17.20 | 05/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097776274 | CMS |
| Novo Nordisk Inc | $19.08 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097782519 | CMS |
| Optinose US, Inc. | $19.92 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142193880 | CMS |
| SHIELD THERAPEUTICS INC | $15.71 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150133025 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.